Relationship Between Maintenance of Healed Erosive Esophagitis and Percent Time with Intragastric pH > 4
David A. Johnson(University of Chicago), Tore Lind(Skaraborg Hospital), Magnus Åstrand(AstraZeneca (Sweden)), Kerstin Röhss(AstraZeneca (Sweden)), Doug Levine(AstraZeneca (United Kingdom)), Ola Junghard(AstraZeneca (Sweden))
Cited by 0
Related Papers
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
|Circulation|2008|845
Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
|Helicobacter|1996|575
The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
|Gastroenterology|1999|433
Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile-Associated Diarrhea
|Clinical Infectious Diseases|2006|204
Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole
|Alimentary Pharmacology & Therapeutics|2001|175